Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Carlsbad, CA, May 14, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade", "Palisade Bio" or the "Company"), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today reported its financial results for the first quarter 2024 and provided a business update. Recent Highlights "Our team remains focused on advancing PALI-2108 towards our first-in-human study, which is on track to start late ...